Comparative in vitro Activity and Clinical Outcomes of Eravacycline, Tigecycline, and Omadacycline Against Carbapenem-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
Current evidence indicates that ERV exhibits strong in vitro bactericidal activity and demonstrates more favorable clinical efficacy comparable to that of TGC against CRKP and CRAB infections, as observed in our retrospective clinical cohort.
Authors
- Jingrong Cao
- P.F. Wang
- Yuan Liu (ORCID: https://orcid.org/0009-0001-1472-200X)
- Wenshuo Yang (ORCID: https://orcid.org/0009-0006-3506-1104)
- Diandian Chen (ORCID: https://orcid.org/0000-0003-4578-1720)
- He Lan
- Rong Min (ORCID: https://orcid.org/0000-0003-0022-3565)
- Dequan Tian
- Leyang Ju
- Yan Wang
- Ying Li
- Qiao Song
Institutions
- Shanxi Medical University (CN)
- Capital Medical University (CN)
- National Clinical Research Center for Digestive Diseases (CN)
- Shanxi Provincial People’s Hospital (CN)
Publication Details
- Journal
- Infection and Drug Resistance
- Published
- 2026-02-01
- DOI
- https://doi.org/10.2147/idr.s583973
- Primary Topic
- Antibiotic Resistance in Bacteria
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Beijing Municipal Health Commission